IGC Pharma, Inc. (IGC)
NYSE American · Manufacturing · Pharmaceutical preparations
$0.2800−$0.0011 (−0.39%) on the dayAs of the close; data may be delayed.
IGC price, last 12 months
Key stats
- Previous close
- $0.2811
- Open
- $0.2816
- Day range
- $0.2770 – $0.3000
- 52-week range
- $0.2350 – $0.4508
- Volume
- 676.9K
- Avg volume (20 days)
- 573.6K
- Market cap
- $29.2M
Performance
1W−1.8%
1M−9.0%
3M+6.5%
6M+7.5%
YTD−0.5%
1Y−31.5%
vs S&P 500, 1Y−48.3 pts
Technicals and fundamentals
About IGC Pharma, Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE American
- Market cap
- $29.2M